Sharon Goswami Co‑Authors New York City Bar Association Patents Committee Comments on USPTO’s Proposed Amendment to Terminal Disclaimer Rules
July 11, 2024
On July 9, 2024, the Committee on Patents of the New York City Bar Association (“Patents Committee”) submitted comments on the proposed amendment from the U.S. Patent and Trademark Office (“USPTO”) to its terminal disclaimer rules, co‑authored by Cravath partner and Patents Committee Chair Sharonmoyee Goswami. The comments discuss the potential implications of the proposed amendment, which would require patent applicants to agree that a patent subject to a terminal disclaimer would be unenforceable if any claim of a patent tied by the terminal disclaimer is found invalid as anticipated or obvious.
Related Practices & Industries
Authors
- Photo
-
-
J.D., 2012, New York University School of LawOrder of the Coif, magna cum laude
-
B.S.E., 2009, Princeton University
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
January 31, 2023
Abiomed Secures Victory Before the U.S. Patent Trial and Appeal Board
In January, 2023, Cravath client Abiomed Inc. (“Abiomed”) secured a victory before the U.S. Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”).
Deals & Cases
September 02, 2022
Illumina Secures Unprecedented Antitrust Trial Win in FTC’s Challenge to GRAIL Acquisition
On September 1, 2022, Chief Administrative Law Judge D. Michael Chappell of the Federal Trade Commission (“FTC”) ruled in favor of Cravath client Illumina, rejecting the FTC’s challenge to Illumina’s $8 billion acquisition of GRAIL, which closed in August 2021.
